Patients with CAD were characterized by a higher level of SGMS1 in epicardial adipocytes (p = 0.006 and p = 0.005 in SAT and PVAT, respectively), while the mRNA levels of SGMS1 in the group of patients with VHD did not exhibit tissue specificity (Figure 4). This evidence concerns the gene SGMS1 and coronary artery disorder.